Zymeworks and Leo Pharma enter licensing and research collaboration for bispecific antibodies Oct. 24, 2018 No Comments
Hisamitsu begins phase II trial in Japan with HP-5070 for primary local hyperhidrosis Oct. 24, 2018 No Comments
New phase II trial explores use of AC-203 for inherited epidermolysis bullosa Oct. 22, 2018 No Comments
DS Biopharma presents positive results from Advance phase IIb study of oral DS-107 Oct. 19, 2018 No Comments
BARDA funding to support pediatric studies of Stratagraft for thermal burns Oct. 16, 2018 No Comments
Phase I/II study of KB-103 meets all primary efficacy and safety endpoints at interim data analysis Oct. 16, 2018 No Comments
Phase III study of Otezla in moderate to severe scalp psoriasis meets primary endpoint Oct. 9, 2018 No Comments
RSS